Windtree Therapeutics Inc... (WINT)
Windtree Therapeutics Statistics
Share Statistics
Windtree Therapeutics has 749.34K shares outstanding. The number of shares has increased by -0.03% in one year.
| Shares Outstanding | 749.34K |
| Shares Change (YoY) | -0.03% |
| Shares Change (QoQ) | 0.07% |
| Owned by Institutions (%) | 0% |
| Shares Floating | 748.36K |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 30.86K, so 0.28% of the outstanding shares have been sold short.
| Short Interest | 30.86K |
| Short % of Shares Out | 0.28% |
| Short % of Float | 0.28% |
| Short Ratio (days to cover) | 0.01 |
Valuation Ratios
The PE ratio is -6.81 and the forward PE ratio is -0.05. Windtree Therapeutics's PEG ratio is 0.08.
| PE Ratio | -6.81 |
| Forward PE | -0.05 |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 40.78 |
| P/FCF Ratio | -10.28 |
| PEG Ratio | 0.08 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Windtree Therapeutics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.35, with a Debt / Equity ratio of 4.96.
| Current Ratio | 1.35 |
| Quick Ratio | 1.35 |
| Debt / Equity | 4.96 |
| Debt / EBITDA | -0.83 |
| Debt / FCF | -1.25 |
| Interest Coverage | -350.78 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1.01M |
| Employee Count | 20 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 0.91, so Windtree Therapeutics's price volatility has been higher than the market average.
| Beta | 0.91 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 3.38 |
| 200-Day Moving Average | 111.96 |
| Relative Strength Index (RSI) | 32.37 |
| Average Volume (20 Days) | - |
Income Statement
| Revenue | n/a |
| Gross Profit | -82K |
| Operating Income | -17.54M |
| Net Income | -20.29M |
| EBITDA | -20.16M |
| EBIT | -20.24M |
| Earnings Per Share (EPS) | -92.23 |
Balance Sheet
The company has 4.32M in cash and 16.83M in debt, giving a net cash position of -12.51M.
| Cash & Cash Equivalents | 4.32M |
| Total Debt | 16.83M |
| Net Cash | -12.51M |
| Retained Earnings | -844.82M |
| Total Assets | 30.45M |
| Working Capital | -10.5M |
Cash Flow
In the last 12 months, operating cash flow was -13.44M and capital expenditures -15K, giving a free cash flow of -13.45M.
| Operating Cash Flow | -13.44M |
| Capital Expenditures | -15K |
| Free Cash Flow | -13.45M |
| FCF Per Share | -61.15 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
WINT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for WINT.
| Price Target | $350 |
| Price Target Difference | n/a |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Feb 21, 2025. It was a backward split with a ratio of 1:50.
| Last Split Date | Feb 21, 2025 |
| Split Type | backward |
| Split Ratio | 1:50 |
Scores
| Altman Z-Score | -40.44 |
| Piotroski F-Score | 0 |